(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | --2.61M | -33.29%1.82M | -39.66%1.96M | -39.66%1.96M | 902.79%2.13M | 290.59%2.73M | 216.67%3.26M | 216.67%3.26M | -88.22%212.43K | -40.67%451.49K |
-Cash and cash equivalents | --2.61M | -33.29%1.82M | -39.66%1.96M | -39.66%1.96M | 902.79%2.13M | 290.59%2.73M | 216.67%3.26M | 216.67%3.26M | -88.22%212.43K | -40.67%451.49K |
-Accounts receivable | --67.92K | 318.59%187.55K | 24.20%33.38K | 24.20%33.38K | 61.82%32.05K | 5.28%44.81K | -42.39%26.88K | -42.39%26.88K | -32.80%19.8K | -0.47%14.07K |
Total current assets | --2.74M | -26.96%2.05M | -38.80%2.02M | -38.80%2.02M | 728.71%2.2M | 236.58%2.8M | 171.20%3.3M | 171.20%3.3M | -87.08%265.24K | -43.28%532.15K |
Non current assets | ||||||||||
-Accumulated depreciation | ---3.15K | -726.90%-2.61K | ---2.03K | ---2.03K | ---1.53K | ---316 | --0 | --0 | ---- | ---- |
-Long term equity investment | --98.28K | --119.19K | --139.58K | --139.58K | --159.47K | ---- | --0 | --0 | ---- | ---- |
-Other intangible assets | ---- | --600.15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Regulatory assets | --67.92K | 318.59%187.55K | 24.20%33.38K | 24.20%33.38K | 61.82%32.05K | 5.28%44.81K | -42.39%26.88K | -42.39%26.88K | -32.80%19.8K | -0.47%14.07K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | --80.48K | --78.17K | --75.91K | --75.91K | --73.71K | ---- | ---- | ---- | ---- | ---- |
-Current capital lease obligation | --80.48K | --78.17K | --75.91K | --75.91K | --73.71K | ---- | --0 | --0 | ---- | ---- |
-accounts payable | --11.28K | -23.01%48.9K | 9.07%564.25K | 9.07%564.25K | --98.66K | --63.52K | 160.27%517.32K | 160.27%517.32K | ---- | ---- |
-Total tax payable | --98.28K | --119.19K | --139.58K | --139.58K | --159.47K | --0 | --0 | --0 | --0 | --0 |
-Due to related parties current | ---- | ---- | ---- | ---- | --419.2K | --325.87K | ---- | ---- | ---- | ---- |
-Other payable | --45K | 0.13%44.55K | -2.35%43.49K | -2.35%43.49K | -1.36%44.45K | 8.30%44.5K | 6.83%44.53K | 6.83%44.53K | 7.58%45.07K | 73.78%42.37K |
Current liabilities | --91.76K | -73.66%127.07K | 4.88%640.16K | 4.88%640.16K | 7.59%591.57K | 112.65%482.37K | 207.09%610.37K | 207.09%610.37K | 50.43%549.84K | 29.16%267.99K |
Non current liabilities | ||||||||||
-Long term debt | --98.28K | --119.19K | --139.58K | --139.58K | --159.47K | ---- | --0 | --0 | ---- | ---- |
Non current accrued expenses | --4.13M | 14.04%4.11M | 23.20%4.17M | 23.20%4.17M | -5.10%4.25M | -0.40%3.6M | -2.44%3.38M | -2.44%3.38M | 46.00%4.47M | 125.21%3.86M |
Total non current liabilities | --190.03K | -48.95%246.26K | 27.75%779.74K | 27.75%779.74K | 36.59%751.04K | 112.65%482.37K | 207.09%610.37K | 207.09%610.37K | 50.43%549.84K | 29.16%267.99K |
Shareholders'equity | ||||||||||
Share capital | --7.44M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 71.54%6M |
-common stock | --7.44M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 0.00%6M | 71.54%6M |
Additional paid-in capital | --613.98K | 21.44%520.62K | 19.55%510.35K | 19.55%510.35K | 17.19%497.82K | 6.47%428.72K | 12.94%426.91K | 12.94%426.91K | 21.51%424.79K | 33.35%418.06K |
Gains losses not affecting retained earnings | --294.39K | 2.03%254.06K | -36.42%160.2K | -36.42%160.2K | -21.51%247.02K | 691.58%249.02K | 2,322.02%251.96K | 2,322.02%251.96K | 1,104.31%314.71K | 359.28%67.73K |
Total equity | --6.91M | -3.87%6.2M | -7.40%6.23M | -7.40%6.23M | 35.62%6.49M | 43.62%6.45M | 42.39%6.73M | 42.39%6.73M | -7.28%4.78M | 65.67%4.43M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.